Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-22

FDA Approved: DIAZEPAM — Supplemental Application (Sunrise Pharmaceutical, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Diazepam submitted by Sunrise Pharmaceutical, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)